Moreover, considering that growing evidence that shows the inhibitory effect of NRF2 in the inflammatory response, the KEAP1-NRF2 antioxidant system can be suggested as an effective target to prevent and/or control chronic renal diseases. This evidence concerns the gene NFE2L2 and chronic kidney disease.